By Summit RCM |
Technological advancements continue to redefine how clinicians treat both chronic and acute wounds. One of the most impactful innovations is low-frequency, non-contact, non-thermal ultrasound therapy, designated under CPT code 97610. This advanced modality has significantly improved outcomes for patients with complex wounds that have failed to respond to conventional treatment approaches.
But what does CPT 97610 truly involve? How does this therapy work in clinical practice, and when is it most appropriate to use? Equally important, how can healthcare providers ensure accurate documentation and compliant billing to support proper reimbursement? This comprehensive guide explores every critical aspect of CPT 97610, from the science behind the technology to its clinical applications, documentation standards, and reimbursement considerations.
The Current Procedural Terminology (CPT) code 97610 is defined as:
“Low-frequency, non-contact, non-thermal ultrasound, including topical application(s), when performed, wound assessment, and instruction(s) for ongoing care, per day.”
This means that CPT 97610 describes a specific modality of wound treatment where ultrasound energy is used at low frequencies (typically 35–40 kHz) to stimulate tissue repair without generating heat. Traditional ultrasound therapy for musculoskeletal injuries requires direct contact with the skin, whereas this advanced approach delivers energy through a fine saline mist, allowing non-contact treatment of the wound bed.
Essentially, it’s a gentle yet powerful therapy designed to accelerate healing through mechanical stimulation, microstreaming, and cellular activation rather than thermal effects.
At its core, CPT 97610 represents a therapeutic method that leverages low-frequency sound waves to promote wound healing through several mechanisms:
Low-frequency ultrasound produces acoustic pressure waves that create microscopic bubbles in the fluid around the wound. These bubbles oscillate and collapse in a process known as stable cavitation, generating microstreaming, a microscopic movement of fluid that stimulates cellular activity, enhances blood flow, and disrupts bacterial biofilms.
Biofilms are stubborn colonies of bacteria encased in protective matrices that prevent antibiotics from working effectively. Ultrasound energy breaks up these structures, allowing antimicrobial treatments to penetrate more effectively and the immune system to respond more efficiently.
Studies have shown that ultrasound energy stimulates fibroblast proliferation, angiogenesis, and collagen synthesis, which are all critical phases in wound repair. It essentially “wakes up” dormant cells in chronic wounds that have stalled in the healing process.
Because the energy is non-thermal, the risk of tissue damage is minimal. The therapy does not raise the temperature of the wound bed, making it safe for delicate tissues and sensitive patients.
CPT 97610 is not for every wound. It is reserved for cases where conventional wound care modalities such as debridement, dressings, and compression have not achieved the desired results.
Ultrasound therapy can also complement debridement and advanced biologic dressings by improving wound bed preparation, ensuring the area is receptive to grafts and cellular products.
The application of CPT 97610 therapy follows a structured, evidence-based process designed to maximize wound healing while ensuring patient comfort and safety.
– Before starting therapy, the clinician assesses wound characteristics such as size, depth, exudate, and tissue viability. This establishes a baseline for tracking progress.
– The ultrasound generator is calibrated to deliver low-frequency sound waves (35–40 kHz). A sterile saline mist is used to carry the ultrasound energy to the wound bed.
– The clinician holds the ultrasound handpiece approximately 1–2 centimeters away from the wound surface. The treatment typically lasts 3–5 minutes per wound, depending on size and clinical judgment.
– After therapy, the wound is reassessed and dressed appropriately. The provider documents wound response and educates the patient on continued care, per CPT 97610’s definition.
Accurate documentation is essential not only for reimbursement but also to demonstrate the medical necessity of the procedure.
Properly detailed documentation protects against claim denials and ensures compliance with payer guidelines.
Proper billing and reimbursement practices are key to successfully integrating CPT 97610 into a wound care program while ensuring providers are fairly compensated for their services.
CPT 97610 is billed per day, regardless of the number of wounds treated or total duration. If multiple wounds are treated in a single session, you report one unit for the total encounter.
This code has no global period, meaning it can be reported each day it is medically necessary and performed.
Payers often expect the service to be used 2–3 times per week, depending on wound severity and progress. Excessive frequency without justification may raise red flags.
Modifier 59 may be required if CPT 97610 is performed in conjunction with other wound care codes (e.g., 97597, 97598, 11042–11047) to indicate distinct procedural service.
Ensure the documentation clearly supports the separate and distinct nature of each service. Since modifiers often determine claim approval, our article on The Role of Modifiers in Wound Care Coding offers valuable insights for maintaining compliance.
Most major insurers, including Medicare, recognize CPT 97610 as a covered service when deemed medically necessary. However, coverage policies may vary by region and payer, so providers should verify local coverage determinations (LCDs).
| CPT Code | Description | Key Difference |
|---|---|---|
| 97597 | Debridement (first 20 sq cm) | Involves removal of devitalized tissue; contact-based |
| 97598 | Debridement (each additional 20 sq cm) | Add-on code for 97597 |
| 97602 | Non-selective debridement | Does not require anesthesia; less specific |
| 97605 / 97606 | Negative pressure wound therapy | Mechanical suction; different mechanism |
| 97607 / 97608 | Low-frequency ultrasound (contact type) | Uses direct contact transducer, unlike 97610 |
CPT 97610 specifically denotes non-contact ultrasound, differentiating it from contact-based or debridement codes.
Several clinical studies and case series support the efficacy of low-frequency non-contact ultrasound therapy in wound care.
Hospitals and wound care centers have reported impressive outcomes, particularly for venous leg ulcers and diabetic foot ulcers, where chronic inflammation and poor perfusion impede progress.
As with many advanced wound care therapies, CPT 97610 is frequently surrounded by misconceptions that deserve clarification.
To achieve optimal clinical and administrative results, clinicians should follow a set of practical best practices when using CPT 97610.
Patient: 68-year-old male with a 12-week-old diabetic foot ulcer unresponsive to standard dressings and offloading.
Intervention:
Results: After 4 weeks, the wound area reduced by 60%, granulation tissue increased significantly, and no signs of infection persisted. By week 8, the wound fully closed.
This case underscores how ultrasound therapy can reactivate stalled healing and restore tissue integrity when other options fail.
As wound care shifts toward regenerative medicine and technology-assisted healing, modalities like non-contact ultrasound will continue to expand. Future innovations may integrate AI-driven wound analytics and smart ultrasound devices that adjust energy output based on real-time tissue feedback.
With ongoing research and growing payer recognition, CPT 97610 is likely to remain a cornerstone of advanced wound management strategies in the coming decade.
To learn how specialized billing support can directly improve financial performance, read our article on How Wound Care Billing Services Boost Practice Revenue.
CPT 97610 represents more than an advanced wound care modality. It reflects the growing intersection of clinical innovation and precise medical coding.
For healthcare providers, understanding the clinical value of CPT 97610 is only part of the equation. Accurate documentation, correct coding, and payer-specific billing strategies are essential to ensure that this powerful therapy translates into appropriate revenue.
At Summit RCM, we specialize in delivering Medical Revenue Cycle Management Services that help wound care centers, hospitals, and specialty practices navigate the complexities of coding, billing, and reimbursement with confidence. Our expert-driven revenue cycle solutions ensure that advanced therapies like CPT 97610 are coded accurately, reimbursed fully, and aligned with regulatory requirements.